RecruitingNot ApplicableNCT07451951

Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in Young Children

Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in Young Children: An Individually Randomized, Parallel-Group, Non-Inferiority Trial


Sponsor

Aga Khan University

Enrollment

1,568 participants

Start Date

Feb 26, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

Nutrition is essential for a child's growth, brain development, and protection from disease. While breastmilk provides the best nutrition for young infants, children older than six months may not get all the nutrients they need from breastmilk and regular foods alone. For this reason, some children receive special nutrient supplements to support healthy growth. Lipid-based nutrient supplements (LNS) are one type of supplement that provides important vitamins and minerals. These supplements are used in many countries to help prevent undernutrition in young children. In Pakistan, the government-led multisectoral nutrition program under the social safety net program currently provides medium-quantity LNS to children starting at six months of age. However, it is not known whether a smaller-quantity LNS could provide similar benefits for children in this age group from under-resourced communities that have limited access to nutritious foods. The goal of this trial is to learn whether small-quantity lipid-based nutrient supplements (SQ-LNS) work as well as medium-quantity lipid-based nutrient supplements (MQ-LNS) in preventing undernutrition in children aged 6 to 12 months. The main questions this study aims to answer are: * Does SQ-LNS work as well as MQ-LNS in supporting healthy growth, including reducing stunting, wasting, and underweight? * Does SQ-LNS work as well as MQ-LNS in reducing anemia? Researchers will compare SQ-LNS and MQ-LNS to see if SQ-LNS is as good as MQ-LNS in preventing undernutrition. The study is being conducted in Dadu and Peshawar, Pakistan. Participants will be followed until 12 months of age. Participants will: * Receive either SQ-LNS or MQ-LNS once daily until 12 months of age * Have their length, weight and mid-upper arm circumference (MUAC) measured monthly * Have their blood screened for anemia at enrollment and at 12 months of age


Eligibility

Min Age: 26 WeeksMax Age: 33 Weeks

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Medium-quantity lipid-based nutrient supplement (MQ-LNS) and Small-quantity lipid-based nutrient supplement (SQ-LNS) for people with undernutrition. The study is currently recruiting participants at 2 locations.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTMedium-quantity lipid-based nutrient supplement (MQ-LNS)

50 g/day lipid-based nutrient supplement providing energy and essential micronutrients, administered daily for 6 months.

DIETARY_SUPPLEMENTSmall-quantity lipid-based nutrient supplement (SQ-LNS)

20 g/day lipid-based nutrient supplement providing energy and essential micronutrients, administered daily for 6 months.


Locations(2)

BNP Facilitation Centers

Peshawar, Khyber Pakhtunkhwa, Pakistan

BNP Facilitation Centers

Dadu, Sindh, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07451951


Related Trials